Journal
AMERICAN JOURNAL OF MEDICINE
Volume 120, Issue 1A, Pages 28-29Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2006.11.005
Keywords
dopaminergic agonists; gabapentin; pramipexole; restless legs syndrome; ropinirole
Categories
Ask authors/readers for more resources
Despite advances in the management of restless legs syndrome (RLS), there still is a great deal of uncertainty about its etiology, pathophysiology, therapy, and clinical outcomes. Much remains to be learned. Future research on these issues will help identify the optimum therapeutic approach for the diverse group of patients with RLS. (c) 2007 Elsevier Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available